Greatmark Investment Partners, Inc. Novartis Ag Transaction History

Greatmark Investment Partners, Inc.

$737 Million
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 23, 2021	SELL	$85.24 - $94.15 $1.69 Million - $1.86 Million	-19,798 Closed	0 $0
Q1 2021 May 04, 2021	SELL	$83.5 - $98.47 $32,565 - $38,403	-390 Reduced 1.93%	19,798 $1.69 Million
Q4 2020 Feb 08, 2021	SELL	$78.07 - $94.43 $48,247 - $58,357	-618 Reduced 2.97%	20,188 $1.91 Million
Q3 2020 Oct 28, 2020	BUY	$82.14 - $91.0 $3,942 - $4,368	48 Added 0.23%	20,806 $1.81 Million
Q2 2020 Aug 04, 2020	SELL	$80.93 - $91.1 $27,030 - $30,427	-334 Reduced 1.58%	20,758 $1.81 Million
Q1 2020 Apr 29, 2020	BUY	$70.67 - $99.01 $52,295 - $73,267	740 Added 3.64%	21,092 $1.74 Million
Q4 2019 Jan 31, 2020	BUY	$84.35 - $95.37 $93,628 - $105,860	1,110 Added 5.77%	20,352 $1.93 Million
Q3 2019 Oct 30, 2019	SELL	$85.54 - $94.26 $54,317 - $59,855	-635 Reduced 3.19%	19,242 $1.67 Million
Q2 2019 Aug 05, 2019	BUY	$75.4 - $92.8 $93,496 - $115,072	1,240 Added 6.65%	19,877 $1.82 Million
Q1 2019 May 07, 2019	BUY	$75.32 - $86.15 $46,773 - $53,499	621 Added 3.45%	18,637 $1.79 Million
Q4 2018 Feb 01, 2019	BUY	$73.66 - $82.02 $150,266 - $167,320	2,040 Added 12.77%	18,016 $1.55 Million
Q3 2018 Oct 31, 2018	BUY	$66.94 - $77.43 $232,281 - $268,682	3,470 Added 27.75%	15,976 $1.38 Million
Q2 2018 Aug 03, 2018	BUY	$64.91 - $73.36 $47,124 - $53,259	726 Added 6.16%	12,506 $945,000
Q1 2018 May 04, 2018	BUY	$70.39 - $84.15 $21,468 - $25,665	305 Added 2.66%	11,780 $952,000
Q4 2017 Feb 01, 2018	SELL	$72.33 - $77.64 $53,524 - $57,453	-740 Reduced 6.06%	11,475 $963,000
Q3 2017 Nov 02, 2017	BUY	$74.14 - $77.27 $905,620 - $943,853	12,215	12,215 $1.05 Million

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greatmark Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Greatmark Investment Partners, Inc. with notifications on news.

Account